These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23685504)

  • 21. Late-Onset Post-transplantation Central Nervous System Lymphoproliferative Disorder: Case Report.
    Rego Silva J; Macau RA; Oliveira Coelho H; Camelo F; Cruz P; Mateus A; Oliveira A; Oliveira C; Ramos A
    Transplant Proc; 2018 Apr; 50(3):857-860. PubMed ID: 29661453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage.
    Crane GM; Powell H; Kostadinov R; Rocafort PT; Rifkin DE; Burger PC; Ambinder RF; Swinnen LJ; Borowitz MJ; Duffield AS
    Oncotarget; 2015 Oct; 6(32):33849-66. PubMed ID: 26460822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Posttransplant Lymphoproliferative Disease Following Pancreas Transplantation: A 40 Year Single-Center Experience.
    Matar AJ; Finger EB; Maakaron J; Minja E; Ramanathan K; Humphreville V; Rao JS; Fisher J; Sutherland DER; Matas AJ; Kandaswamy R
    Clin Transplant; 2024 Aug; 38(8):e15386. PubMed ID: 39087488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
    Steiner R; Kridel R; Giostra E; McKee T; Achermann R; Mueller N; Manuel O; Dickenmann M; Schuurmans MM; de Leval L; Fehr T; Tinguely M; Binet I; Cogliatti S; Haralamvieva E; Koller M; The Swiss Transplant Cohort Study Stcs ; Dietrich PY
    Swiss Med Wkly; 2018; 148():w14596. PubMed ID: 29518251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-transplant primary central nervous system lymphoma after Epstein-Barr virus cerebellitis.
    Valencia-Sanchez C; Steenerson KK; Kelemen K; Orenstein R; Kusne S; Grill MF
    J Neurovirol; 2019 Apr; 25(2):280-283. PubMed ID: 30607891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary Epstein-Barr virus infection, seroconversion, and post-transplant lymphoproliferative disorder in seronegative renal allograft recipients: a prospective cohort study.
    Hosseini-Moghaddam SM; Alhomayeed B; Soliman N; Weir MA; House AA
    Transpl Infect Dis; 2016 Jun; 18(3):423-30. PubMed ID: 27016725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT; Purakal A; Pytel P
    J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Late-Onset Central Nervous System Posttransplant Lymphoproliferative Disorder After Lung Transplantation:A Case Report.
    Ose N; Minami M; Funaki S; Kanou T; Fukui E; Morii E; Shintani Y
    Transplant Proc; 2019 Nov; 51(9):3163-3166. PubMed ID: 31619339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of posttransplantation lymphoproliferative disorder (PTLD) following renal allografting is associated with sustained CD8(+) T-cell restoration.
    Porcu P; Eisenbeis CF; Pelletier RP; Davies EA; Baiocchi RA; Roychowdhury S; Vourganti S; Nuovo GJ; Marsh WL; Ferketich AK; Henry ML; Ferguson RM; Caligiuri MA
    Blood; 2002 Oct; 100(7):2341-8. PubMed ID: 12239141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.
    Ganne V; Siddiqi N; Kamaplath B; Chang CC; Cohen EP; Bresnahan BA; Hariharan S
    Clin Transplant; 2003 Oct; 17(5):417-22. PubMed ID: 14703923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttransplant lymphoproliferative disorders of the central nervous system after kidney transplantation: single center experience over 40 years. Two case reports.
    Arita H; Izumoto S; Kinoshita M; Okita Y; Hashimoto N; Fujita T; Ichimaru N; Takahara S; Yoshimine T
    Neurol Med Chir (Tokyo); 2010; 50(12):1079-83. PubMed ID: 21206182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraventricular rituximab and systemic chemotherapy for treatment of central nervous system post-transplant lymphoproliferative disorder after kidney transplantation.
    Twombley K; Pokala H; Ardura MI; Harker-Murray P; Johnson-Welch SF; Weinberg A; Seikaly M
    Pediatr Transplant; 2012 Sep; 16(6):E201-9. PubMed ID: 22646132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings.
    Hoyt D; Hughes J; Liu J; Ayyad H
    Radiol Case Rep; 2024 Jun; 19(6):2168-2182. PubMed ID: 38515768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical management of perforated gastrointestinal posttransplantation lymphoproliferative disorder after heart transplantation.
    Osawa H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int Surg; 2015 Feb; 100(2):358-64. PubMed ID: 25692442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extremely delayed-onset post-transplant lymphoproliferative disorder in a renal transplant patient.
    Holland E; Altshuler E; Franke AJ
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 35977750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder following lung transplantation is more commonly of host origin.
    Peterson MR; Emery SC; Yung GL; Masliah E; Yi ES
    Arch Pathol Lab Med; 2006 Feb; 130(2):176-80. PubMed ID: 16454557
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human leukocyte antigen type and posttransplant lymphoproliferative disorder.
    Lustberg ME; Pelletier RP; Porcu P; Martin SI; Quinion CD; Geyer SM; Caligiuri MA; Baiocchi RA
    Transplantation; 2015 Jun; 99(6):1220-5. PubMed ID: 25427163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
    Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
    Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus-related posttransplantation lymphoproliferative disorder involving pancreas allografts: histological differential diagnosis from acute allograft rejection.
    Drachenberg CB; Abruzzo LV; Klassen DK; Bartlett ST; Johnson LB; Kuo PC; Kumar D; Papadimitriou JC
    Hum Pathol; 1998 Jun; 29(6):569-77. PubMed ID: 9635676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttransplantation lymphoproliferative disorder in children: clinical, histopathologic, and imaging features.
    Pickhardt PJ; Siegel MJ; Hayashi RJ; Kelly M
    Radiology; 2000 Oct; 217(1):16-25. PubMed ID: 11012419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.